The following discussion and analysis should be read together with our consolidated financial statements and the related notes appearing elsewhere in this Report. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See "Forward-Looking Statements" for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under "Risk Factors" and elsewhere in this Report.





Overview


The Company was established under the laws of the State of Nevada on February 17, 2017 as Tiburon International Trading Corp. Tiburon was established as a development stage company focusing its business on the distribution of air infiltration valves manufactured in China to markets in Europe and in the Commonwealth of Independent States (CIS). On October 5, 2020, Kryptos Art Technologies, Inc. ("Kryptos"), an Ontario corporation purchased 2,500,000 shares of Tiburon from Yun Cai, who was the Chief Executive Officer, President, Chief Financial Officer and Sole Director of Tiburon. As a result of this sale, Kryptos became the majority shareholder of Tiburon. The shares owned by Kryptos represented approximately 71.87% of Tiburon's outstanding common stock. The purchase price was $232,467. The funds were funds of Kryptos. Kryptos is controlled by recently-departed Company CEO, Brian McWilliams.

Mr. McWilliams was appointed the Company's Chief Executive Officer on October 5, 2020. On October 8, 2020, Kryptos, as the holder of approximately 71% of the voting stock of the Company executed a shareholder consent to effect a name change of the Tiburon to Fact, Inc. Under Mr. McWilliams' management, the Company wound down operations of the historic Tiburon business, which has largely been curtailed by prior management because of COVID-19 and lack of capital necessary for expansion of the website and product offerings. Kryptos had been working on a technology designed to detect and eliminate fraud in the art world. Kryptos has assigned all of its technological know-how in this area to the Company which we will pursue as our primary business operations. In connection therewith, the Company has entered into and is negotiating a series of development and consulting agreements with software and hardware developers to complete the development of our products. The Company expects to enter into a license agreement to utilize fraud detection technology in the art area. The Company expects to enter into such license agreement with an award winning forensic ballistic technology company that revolutionized the Criminal Justice system's approach to ballistics.

On October 8, 2020, Kryptos, as the holder of approximately 71% of the voting stock of Tiburon, executed a shareholder consent to effect a name change of Tiburon to Fact, Inc. FACT is a leading innovator of bringing forensic technology to the art world. FACT stands for Forensic Asset Certification Technology. Using white light interferometry, FACT takes a non-destructive 3D digital fingerprint of the art using over 100,000 unique images. These scans, measured at two (2) microns, equal to 1/50th of a human hair, are unable to be reproduced or forged. Scans are compared to one another by a computer algorithm to verify the paintings authenticity.

All data is stored securely on the block-chain for real time collection management. We are currently developing a front-end user interface as well as modifying existing ballistics firmware for a comprehensive verification, tracking and reporting system. A workable prototype (the "Prototype") is expected to be ready during the Company's second quarter ending July 31, 2020.





9





We plan to market to various channels in different capacities including, but not limited to, subscription models, leasing models, and individual point of sale models. The fees for our different models will range from a flat fee to a percentage of sales fee. We are hopeful the Company will commence its marketing efforts in the Company's first quarter ending April 30, 2022, with the hope that the product may launch by the end of the Company's second quarter ending July 31, 2022.

On March 22, 2021, Mr. McWilliams left the Company and was replaced by Ms. Patricia Trompeter as Chief Executive Officer.





Research and Development


Research and development expenses consists of costs incurred while performing research and development activities to discover and develop our product. This includes conducting studies and trials, manufacturing development efforts and activities. We recognize research and development expenses as they are incurred. Our research and development expense primarily consist of:





  ? forensic technology product testing and regulatory-related costs;

  ? expenses incurred under agreements with investigative sites and consultants
    that conduct our product testing;

  ? manufacturing and testing costs and related supplies and materials;

  ? employee-related expenses, including salaries, benefits, travel and
    stock-based compensation; and

  ? facility expenses dedicated to research and development.



We typically use our employee, consultant and infrastructure resources across our development programs. We track outsourced development costs by product or development program, but we do not allocate personnel costs, other internal costs or external consultant costs to specific product or development programs.

Substantially all of our research and development expenses to date have been incurred in connection with our product. We expect our research and development expenses to increase significantly for the foreseeable future as we advance an increased number of our product through development. The successful development of product is highly uncertain. At this time, we cannot reasonably estimate the nature, timing or costs required to complete the remaining development of any product. This is due to the numerous risks and uncertainties associated with the development of product.

We do not expect any of our products to be commercially available until the end of the Company's second quarter ending July 31, 2022. We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future, which may fluctuate significantly from quarter-to-quarter and year-to-year. We anticipate that our expenses will increase substantially as we:





  ? continue research and development, including development of our existing
    product;

  ? seek to discover and develop additional product;

  ? establish a commercialization infrastructure and scale up our manufacturing
    and distribution capabilities to commercialize any of our product for which we
    may obtain regulatory approval;

  ? seek to comply with regulatory standards and laws;

  ? maintain, leverage and expand our intellectual property portfolio;




10






  ? hire manufacturing, scientific and other personnel to support our product
    development and future commercialization efforts;

  ? add operational, financial and management information systems and personnel;
    and

  ? incur additional legal, accounting and other expenses in operating as a public
    company.



Results of Operations for years ended January 31, 2021 and 2020

The following tables set forth certain selected condensed statement of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance as they relate to the Company's historic business.





                                       Year ended
                                       January 31                 Variation
                                   2021           2020          $           %
Revenue                         $         -     $  4,500
Cost of Goods sold              $         -     $  2,700
Gross Profit                    $         -     $  1,800
Operating Expenses              $   447,374     $ 25,585

Income (loss) from operations $ 1,260,691 $ 23,785 Net Loss per common Share $ 0.02 $ 0.01






Revenues


During the year ended January 31, 2021, the Company did not generate any revenue compared to $4,500 during the year ended January 31, 2020. The cost of revenue was $0.

A workable Prototype is expected to be ready during the Company's first quarter ending April 30, 2022, with rollout starting by the end of the Company's second quarter ending July 31, 2022. Revenue are expected to be generated, although there can be no assurance, from several key channels as outlined below.

FACT will be marketed to five (5) main channels with a variety of ancillary packages:





  (1) Financial Markets - Art Insurance & Art Secured Lending
  (2) Sales Markets - Auction Houses, Art Dealers, & Gallery Sales
  (3) Logistics Markets - Shipping/Transport Companies, Storage facilities, &
      Ancillary Services
  (4) Collectors Market - Private Museums, Institutions & Collectors
  (5) Individual Market - Scans at an select FACT location



FACT is hopeful that it will also have an ancillary channel: Leasing of FACT device and software to clients who want unlimited on demand scans which can be added on any of the above subscription packages.

Each channel will be priced in a different capacity to reflect the service provided to such channel. Revenues are expected from the following areas:





  ? Individual scans - Scans for individuals who want one or two time FACT Scans.

  ? Salesman Package - These are scans that would be purchased by Auction houses,
    dealers, and gallery owners to verify that the painting is authentic as well
    as verification in the shipping/logistics process.




11






  ? Financial package - Art Insurers and Art Secured Lenders would use FACT to
    ensure that the painting they are inuring/lending against is not a forgery. In
    addition, if the painting is held as collateral, the owner can make sure that
    the painting returned is authenticated.

  ? Logistics package - Warehouse and Shipping experts who specialize in art would
    use the FACT system to verify the painting that left point A is the same that
    arrived at point B. In addition, FACT's GPS system provides real time location
    tracking.

  ? Collectors package - Private museums, Foundations, & Institution Collectors
    would use the FACT system to authenticate a piece of art that for example was
    loaned to a museum for an exhibit.



Operation, General and Administrative Expenses

General and administrative expenses for the years ended January 31, 2021 and 2020 totaled $447,374 and $25,585, respectively, representing a 1600% increase. The increases are primarily attributed to expenses related to consulting fees and legal fees.

Liquidity and Capital Resources

Initially, we anticipate the Company will be funded from investors, through the sale of debt or equity securities.

On November 20, 2020, Fact, Inc. the Company and Oasis Capital, LLC ("Oasis") entered into a Securities Purchase Agreement (the "Note Purchase Agreement") pursuant to which the Company agreed to sell and Oasis agreed to purchase $730,000 principal amount of convertible promissory notes (the "Note") for a purchase price of $610,000 which includes a 20% original issue discount and $10,000 of expenses. On November 20, 2020, Oasis funded $250,000 (the "First Tranche") and the Company in turn agreed to issue to Oasis a note in the principal amount of $310,000. Under the Note Purchase Agreement, the Company will sell Oasis an additional promissory note in the principal amount of $420,000 and issue an additional note for a purchase price of $350,000 (the "Second Tranche") upon the Company's filing of a registration statement with the Securities and Exchange Commission (the "SEC"), pursuant to the registration rights agreement (the "Registration Rights Agreement") entered into by and between the Company. The maturity date for each of the First Tranche and the Second Tranche is six (6) months from the date on which Oasis funds the respective portion of the Note. The interest rate of the Note is 10% annum. The Note is convertible into shares of the Company's common stock, par value $.001 (the "Common Stock") at the option of the holder. The "Conversion Price" per share shall be the lesser of (i) $2.00 per share and (ii) 65% of the lowest traded price of the Common Stock as reported on the Trading Market during the 30 consecutive Trading Day (as defined in the Note Purchase Agreement) period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Notice of Conversion.

In addition, in connection with the Note Purchase Agreement, the Company issued to Oasis 100,000 shares of Common Stock and a five year warrant (the "Warrant") to purchase up to 291,775 shares of Common Stock at a price equal to $1.10 per share.

On November 20, 2020, the Company and Oasis entered into an Equity Purchase Agreement (the "Equity Purchase Agreement")"), whereby Oasis has committed to purchase $10,000,000 worth of Common Stock, as requested by the Company (the "Equity Line"). The Company's ability to draw upon the Equity Line is subject to the effectiveness of a registration statement with the SEC and certain other contingencies. The Company entered into the Registration Rights Agreement with Oasis pursuant to the Equity Purchase Agreement..

In connection with the EPA, the Company issued to Oasis an aggregate amount of 250,000 shares of Common Stock, of which 100,000 shares will be restricted until Oasis funds at least $1,000,000 under the Equity Line. Purchases made under the EPA will be made at a 15% discount under market price. Market price under the Equity Purchase Agreement is defined as 85% of the lowest traded price during the five consecutive trading days following the date Oasis receives the shares.





12





We may raise additional funds through the sale of debt and/or equity in the future.

We anticipate that material expenditures in the next six (6) months will include development costs for the software and the firmware as well purchases of the hardware. The Company estimates that development of the Prototype should cost approximately $500,000 to $700,000 in upfront software and firmware development costs. The Company also anticipates it will require several pieces of hardware, including, but not limited to, an interferometer, scanning arms, vans, computers, monitors, and other related items. The Company anticipates costs of approximately $2,000,000 with associated hard assets. We are in the process of selecting a software development firm to assist us with the prototype.

While we are hopeful that the initial capital expenditures will be covered by investor funds (see the description of the Equity Purchase Agreement above for detailed explanation), ongoing cash flows from operations will fund future expenditures. We anticipate that future expenditures post product launch by the end of the Company's second quarter ending July 31, 2022, will include normal expenses from operations, including, but not limited to, salaries, R&D, PP&E purchases, and marketing expenses. We anticipate there will be ongoing research and software development as the Company expands into future lines of business such as other collectibles.

Cash flows from operations are expected to commence at the beginning of the Company's second fiscal quarter ending July 31, 2022, slowly increasing at a slight percentage until the end of the Company's 2022 year end. The Company expects its operations to result in negative net cash flow throughout the Company's 2022 end. Towards the end of 2022, the Company expects to increase net cash flow due to an anticipated increase in the Company's expected revenue and a decrease in its expected R&D expenditures for the Company's fourth quarter of 2022, as compared to the Company's expected revenue and R&D expenditures, respectively, for the Company's first quarter ending April 30, 2022. There can be no assurances that the Company will achieve any revenues in 2022.





Cash Flows


For the year ended January 31, 2021, net cash flows used in operating activities were negative as the company entered into contracts to develop the software and there were no associated revenues. As a startup - the product is in development and therefore the company did not recognize any revenue during this time.

Off Balance Sheet Arrangements

As of the date of this Annual Report, we do not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Significant Accounting Policies

For a discussion of the Company's significant accounting policies please refer to Note 3 of the Company's financial statements included herein.





Revenue Recognition


We adopted Accounting Standards Codification ("ASC") Topic 606, "Revenue from Contracts with Customers", and all related interpretations for recognition of our revenue. Previously we recorded revenue based on ASC Topic 605. Adoption of new accounting standard did not have any material impact on our reported revenue.





13





Basic and Diluted Income (Loss) Per Share

The Company computes income (loss) per share in accordance with FASB ASC 260 "Earnings per Share". Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of January 31, 2021, there were no potentially dilutive debt or equity instruments issued or outstanding.





Cash and Cash Equivalents


For purposes of the statement of cash flows, the Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company's bank accounts are deposited in insured institutions. The funds are insured up to $250,000. At January 31, 2021, the Company's bank deposits did not exceed the insured amounts.





Stock-Based Compensation


As of January 31, 2021, the Company has not issued any stock-based payments to its employees.

Stock-based compensation is accounted for at fair value in accordance with ASC 718, when applicable. To date, the Company has not adopted a stock option plan and has not granted any stock options.





Use of Estimates


Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Actual results and outcomes may differ from management's estimates and assumptions.





Income Taxes


The Company follows the liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.





COVID-19


The novel coronavirus ("COVID-19") was first identified in late 2019. COVID-19 spread rapidly throughout the world and, in March 2020, the World Health Organization ("WHO") characterized COVID-19 as a pandemic. COVID-19 is a pandemic of respiratory disease spreading from person-to-person that poses a serious public health risk. It has significantly disrupted supply chains and businesses around the world. The extent and duration of the COVID-19 impact on our operations and financial position is highly uncertain.

Management continues to closely monitor and evaluate the impact of the COVID-19 pandemic on the Company's operations and will take, the necessary actions to right-size the business in this environment, which is evolving daily. Some potential actions include, but are not limited to, modified work schedules as well as appropriate adjustments to the operating expenditures and capital spending plans.

The Company is not able to predict the ultimate impact that COVID -19 will have on its new business; however, if the current economic conditions continue, the Company will be forced to significantly scale back its business operations and its growth plans, and could ultimately have a significant negative impact on the Company.

Recently Issued Accounting Pronouncements

The Company has no material items to report at this time.

14

© Edgar Online, source Glimpses